Why did FCG.AX stock spike in volume today?

The spike to **1,184,838** shares likely reflects a block trade or short-term repositioning in a thin market. No major company announcement matched the spike intraday; watch the ASX order book and any follow-up notices for confirmation.

Is FCG.AX stock undervalued versus peers?

Valuation metrics point to a discount: trailing P/E ~**4.50** and price-to-book **0.75** versus Healthcare averages. Lower scale and execution risk mean the valuation gap may persist without clear growth catalysts.

What price target does Meyka AI give for FCG.AX stock?

Meyka AI's forecast model projects a baseline **A$0.10** in 12 months, implying **170.27%** upside from **A$0.037**. Forecasts are model-based projections and not guarantees.

How should traders manage risk in FCG.AX stock after a volume spike?

Use small position sizes, limit orders, and tight stops that accommodate three-decimal moves. Given market cap **A$4.01M** and wide spreads, avoid oversized exposures and set exit rules before entering trades.

AU Stocks

Volume 1,184,838 spikes in FCG.AX Freedom Care Group (ASX) 13 Jan 2026: Monitor upside

ByHuzaifa Zahoor January 13, 2026January 13, 2026

We saw a volume spike of 1,184,838 shares in FCG.AX stock intraday on 13 Jan 2026, driven by unusually high turnover versus the 30-day average of 30,060 shares. The price opened at A$0.059, traded as high as A$0.059, and sits at A$0.037 currently, highlighting intraday churn and thin liquidity on the ASX. We examine why volume surged, how the move ties to fundamentals and valuation, and what short-term traders should watch for in the Healthcare sector and NDIS services exposure.